REFERENCES:
- Phelan AL, Katz R, Gostin LO. The Novel Coronavirus Originating in
Wuhan, China: Challenges for Global Health Governance [published
online ahead of print, 2020 Jan 30]. JAMA .
2020;10.1001/jama.2020.1097. doi:10.1001/jama.2020.1097.
- Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology
in Wuhan, China: The mystery and the miracle. J Med Virol .
2020;92(4):401‐402. doi:10.1002/jmv.25678.
- Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G,
Mchugh TD, Memish ZA, Drosten C, Zumla A, Petersen E. The continuing
2019-nCoV epidemic threat of novel coronaviruses to global health -
The latest 2019 novel coronavirus outbreak in Wuhan, China. Int
J Infect Dis . 2020;91:264‐266.
- Epidemiology Working Group for NCIP Epidemic Response, Chinese Center
for Disease Control and Prevention. Zhonghua Liu Xing Bing Xue
Za Zhi . 2020;41(2):145-151.
- Kang Y, Chen T, Mui D, Ferrari V, Jagasia D, Scherrer-Crosbie M, Chen
Y, Han Y. Cardiovascular manifestations and treatment considerations
in covid-19. Heart. 2020 Apr 30:heartjnl-2020-317056.
- Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL,
Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen
PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH,
Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ,
Zhu SY, Zhong NS. Clinical Characteristics of Coronavirus Disease 2019
in China. N Engl J Med . 2020;382(18):1708‐1720.
- Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu
X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B.
Clinical course and risk factors for mortality of adult inpatients
with COVID-19 in Wuhan, China: a retrospective cohort study
[published correction appears in Lancet. 2020 Mar
28;395(10229):1038]. Lancet . 2020;395(10229):1054‐1062.
- Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu
Z. Cardiovascular Implications of Fatal Outcomes of Patients With
Coronavirus Disease 2019 (COVID-19) [published online ahead of
print, 2020 Mar 27]. JAMA Cardiol . 2020;e201017.
- Meierhenrich R, Steinhilber E, Eggermann C, Weiss M, Voglic S,
Bögelein D, Gauss A, Georgieff M, Stahl W. Incidence and prognostic
impact of new onset atrial fibrillation in patients with septic shock:
a prospective observational study. Crit Care 2010, 14(3): R108.
- Salman S, Bajwa A, Gajic O, Afessa B. Paroxysmal atrial fibrillation
in critically ill patients with sepsis. J Intensive Care
Med 2008, 23: 178-183.
- Seguin P, Signouret T, Laviolle B, Branger B, Mallédant Y. Incidence
and risk factors of atrial fibrillation in a surgical intensive care
unit. Crit Care Med 2004, 32: 722-726.
- Klein Klouwenberg PM, Frencken JF, Kuipers S, Ong DS, Peelen LM, van
Vught LA, Schultz MJ, van der Poll T, Bonten MJ, Cremer OL. Incidence,
Predictors, and Outcomes of New-Onset Atrial Fibrillation in
Critically Ill Patients with Sepsis. A Cohort Study. American Journal
of Respiratory and Critical Care Medicine. 2017;195(2):205-211.
- Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation
and perpetuation of atrial fibrillation: a systematic review of the
published data. J Am Coll Cardiol 2007, 50: 2021-2028.
- Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z,
Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138
Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia
in Wuhan, China. JAMA . 2020;323(11):1061‐1069.
- Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg
FM, Madhur MS, Tomaszewski M, Maffia P, D’Acquisto F, Nicklin SA,
Marian AJ, Nosalski R, Murray EC, Guzik B, Berry C, Touyz RM, Kreutz
R, Wang DW, Bhella D, Sagliocco O, Crea F, Thomson EC, McInnes IB.
COVID-19 and the cardiovascular system: implications for risk
assessment, diagnosis, and treatment options. Cardiovasc Res .
2020; cvaa106.
- Walkey AJ, Greiner MA, Heckbert SR, Jensen PN, Piccini JP, Sinner MF,
Curtis LH, Benjamin EJ. Atrial fibrillation among Medicare
beneficiaries hospitalized with sepsis: incidence and risk factors.Am Heart J . 2013;165(6):949‐955.e3.
- Kuipers S, Klein Klouwenberg PM, Cremer OL. Incidence, risk factors
and outcomes of new-onset atrial fibrillation in patients with sepsis:
a systematic review. Crit Care . 2014;18(6):688.
- Dittrich HC, Pearce LA, Asinger RW, McBride R, Webel R, Zabalgoitia M,
Pennock GD, Safford RE, Rothbart RM, Halperin JL, Hart RG. Left atrial
diameter in nonvalvular atrial fibrillation: An echocardiographic
study. Stroke Prevention in Atrial Fibrillation
Investigators. Am Heart J . 1999;137(3):494-499.
- Olsen FJ, Møgelvang R, Jensen GB, Jensen JS, Biering-Sørensen T.
Relationship Between Left Atrial Functional Measures and Incident
Atrial Fibrillation in the General Population: The Copenhagen City
Heart Study. JACC Cardiovasc Imaging . 2019;12(6):981-989.
- Fatema K, Barnes ME, Bailey KR, Abhayaratna WP, Cha S, Seward JB,
Tsang TS. Minimum vs. maximum left atrial volume for prediction of
first atrial fibrillation or flutter in an elderly cohort: a
prospective study. Eur J Echocardiogr . 2009;10(2):282-286.
- Chambers RC. Procoagulant signalling mechanisms in lung inflammation
and fibrosis: novel opportunities for pharmacological
intervention?. Br J Pharmacol . 2008;153 Suppl 1(Suppl
1):S367-S378.
- Snijders D, Schoorl M, Schoorl M, Bartels PC, van der Werf TS, Boersma
WG. D-dimer levels in assessing severity and clinical outcome in
patients with community-acquired pneumonia. A secondary analysis of a
randomised clinical trial. Eur J Intern Med .
2012;23(5):436-441.
- Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, Zhang Z. D-dimer levels on
admission to predict in-hospital mortality in patients with
Covid-19. J Thromb Haemost . 2020;18(6):1324-1329.
- Walkey AJ, Wiener RS, Ghobrial JM, Curtis LH, Benjamin EJ. Incident
Stroke and Mortality Associated With New-Onset Atrial Fibrillation in
Patients Hospitalized With Severe
Sepsis. JAMA. 2011;306(20):2248–2254.
- Darwish OS, Strube S, Nguyen HM, Tanios MA. Challenges of
anticoagulation for atrial fibrillation in patients with severe
sepsis. Ann Pharmacother . 2013;47(10):1266‐1271.
- Quon MJ, Behlouli H, Pilote L. Anticoagulant Use and Risk of Ischemic
Stroke and Bleeding in Patients With Secondary Atrial Fibrillation
Associated With Acute Coronary Syndromes, Acute Pulmonary Disease, or
Sepsis. JACC Clin Electrophysiol . 2018;4(3):386‐393.
- Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is
associated with decreased mortality in severe coronavirus disease 2019
patients with coagulopathy. J Thromb Haemost .
2020;18(5):1094‐1099.